Establishment of a Poliovirus Containment Program and Containment Certification Process for Poliovirus-Essential Facilities, United States 2017–2022

Author:

Ottendorfer Christy1,Shelby Bryan1,Sanders Cecelia A.1ORCID,Llewellyn Anna2,Myrick Christy3,Brown Christye4,Suppiah Suganthi1,Gustin Kortney1,Smith Lia Haynes1

Affiliation:

1. Centers for Disease Control and Prevention, Office of Readiness and Response, U.S. National Authority for Containment of Poliovirus, Atlanta, GA 30329, USA

2. Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Atlanta, GA 30329, USA

3. Centers for Disease Control and Prevention, Office of Laboratory Science and Safety, Atlanta, GA 30329, USA

4. Morehouse School of Medicine, Atlanta, GA 30310, USA

Abstract

Upon declaration of poliovirus (PV) type 2 eradication in 2015, the World Health Organization (WHO) published PV containment requirements in the Global Action Plan III (GAPIII) for mitigating the risk of a facility-associated release post eradication. In 2018, the 71st World Health Assembly resolution urged member states retaining PV to appoint a National Authority for Containment (NAC), reduce the number of PV facilities, and submit applications for containment certification. The United States (US) NAC was established in 2018 for containment oversight, and two paths to WHO GAPIII containment certification were developed. Facilities retaining PV were identified through national poliovirus containment surveys. The US NAC conducted 27 site visits at 18 facilities (20 laboratories: A/BSL-2 (65%), A/BSL-3 (20%), and storage-only (15%)) to verify the implementation of US NAC’s preliminary containment measures. The NAC identified areas for improvement in seven categories: primary containment, decontamination, hand hygiene, security, emergency response, training, and immunization practices. Sixteen facility applications were endorsed to pursue poliovirus-essential facility (PEF) certification, whereas four facilities opted to withdraw during the containment certification process. The US made noteworthy progress in PV containment to enhance biosafety and biosecurity practices at US PV facilities to safeguard the polio eradication effort.

Publisher

MDPI AG

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,Molecular Biology,Immunology and Allergy

Reference30 articles.

1. Progress Toward Poliomyelitis Eradication—Worldwide, January 2021–March 2023;Lee;Morb. Mortal. Wkly. Rep.,2023

2. Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease;Strebel;Clin. Infect. Dis.,1992

3. Advisory Committee on Immunization Practices (ACIP) (1999). Revised Recommendations for Routine Poliomyelitis Vaccination. Morb. Mortal. Wkly. Rep., 48, 590.

4. Update on vaccine-derived polioviruses—Worldwide, January 2015–May 2016;Jorba;Morb. Mortal. Wkly. Rep.,2016

5. Cessation of Trivalent Oral Poliovirus Vaccine and Introduction of Inactivated Poliovirus Vaccine—Worldwide, 2016;Hampton;Morb. Mortal. Wkly. Rep.,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3